© 1996 Oxford University Press
research-article |
CANCER BIOLOGY: Analysis of differentiation-associated proteins in rat bladder carcinogenesis
1Department of Pathology and Microbiology and Eppley Institute for Research on Cancer and Allied Diseases, University of Nebraska Medical Center 600 South 42nd Street, Omaha, NE 68198-3135
2Epithelial Biology Unit, The Ronald O.Perelman Department of Dermatology and the Department of Pharmacology, Kaplan Comprehensive Cancer Center, New York University School of Medicine New York, NY 10016, USA
3To whom reprint requests should be addressed
Uroplakins are the major integral membrane proteins synthesized in terminally differentiated, superficial urothel-ial cells. Alteration of cell differentiation during rat urinary bladder carcinogenesis was analyzed immunohistochemi-cally for the expression of uroplakins. Expression of uroplakins was compared in N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide (FANFT)-, uracil-, sodium saccharin- or sodium ascorbate-induced urothelial simple hyperplasia, papillary-nodular hyperplasia, papilloma and carcinoma. In controls, uroplakins were located only in superficial cells, especially the luminal surface membrane. In FANFT-induced hyperplasia, including simple hyperplasia, intermediate cells also stained and the staining pattern was disorderly and intermittent In uracil-induced simple hyperplasia, intermediate cells were stained but in an orderly fashion. In sodium saccharin- or sodium ascorbate-induced simple hyperplasia, superficial cells were swollen but alterations were not observed in the staining pattern. In carcinoma induced by FANFT and uracil, uroplakin expression was very disorderly and focal, usually with no expression on surface cells. It appears that disorderly differentiation is an index of bladder malignancy and is an early event in FANFT-induced lesions but a late event in uracil-, sodium saccharin- and sodium ascorbate-induced lesions.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. A. Ramos-Vara, M. A. Miller, M. Boucher, A. Roudabush, and G. C. Johnson Immunohistochemical Detection of Uroplakin III, Cytokeratin 7, and Cytokeratin 20 in Canine Urothelial Tumors Vet. Pathol., January 1, 2003; 40(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Cohen Comparative Pathology of Proliferative Lesions of the Urinary Bladder Toxicol Pathol, October 1, 2002; 30(6): 663 - 671. [Abstract] [PDF] |
||||
![]() |
V. Ambrosio, G. Borzacchiello, F. Bruno, P. Galati, and F. Roperto Uroplakin Expression in the Urothelial Tumors of Cows Vet. Pathol., November 1, 2001; 38(6): 657 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogawa, M. St. John, M. L. De Oliveira, L. Arnold, T. Shirai, T.-T. Sun, and S. M. Cohen Comparison of Uroplakin Expression During Urothelial Carcinogenesis Induced by N-Butyl-N-(4-Hydroxybutyl)Nitrosamine in Rats and Mice Toxicol Pathol, November 1, 1999; 27(6): 645 - 651. [Abstract] [PDF] |
||||
![]() |
K. Ogawa, S. L. Johansson, and S. M. Cohen Immunohistochemical Analysis of Uroplakins, Urothelial Specific Proteins, in Ovarian Brenner Tumors, Normal Tissues, and Benign and Neoplastic Lesions of the Female Genital Tract Am. J. Pathol., October 1, 1999; 155(4): 1047 - 1050. [Abstract] [Full Text] [PDF] |
||||


